Substance / Medication

Fenoldopam mesylate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Research Evidence

Published studies and systematic reviews

Sort:
Stability of fenoldopam mesylate in two infusion solutions.
Trissel Lawrence A, Zhang Yanping, Baker Mary B · Am J Health Syst Pharm · 2002
PMID: 12004463Observational
Fenoldopam Mesylate: A Narrative Review of Its Use in Acute Kidney Injury.
Noce Annalisa, Marrone Giulia, Rovella Valentina et al. · Curr Pharm Biotechnol · 2019
PMID: 31038062ReviewFull text (PMC)
Effects of fenoldopam mesylate infusion on splanchnic perfusion after myocardial revascularization on cardiopulmonary bypass: an ultrasound Doppler study.
Meco Massimo, Allaz Marie Claire, Cirri Silvia · J Cardiothorac Vasc Anesth · 2011
PMID: 21109463Other
Pharmacokinetics And Pharmacodynamics Of Fenoldopam Mesylate For Blood Pressure Control In Pediatric Patients.
Hammer Gregory B, Verghese Susan T, Drover David R et al. · BMC Anesthesiol · 2008
PMID: 18837982OtherFull text (PMC)
Effect of fenoldopam mesylate in critically ill patients at risk for acute renal failure is dose dependent.
Samuels Joshua, Finkel Kevin, Gubert Matt et al. · Ren Fail · 2005
PMID: 15717642Other
Fenoldopam mesylate for treating psoriasis: A new indication for an old drug.
Doppalapudi Sindhu, Jain Anjali, Khan Wahid et al. · Int J Pharm · 2020
PMID: 31715365Preclinical
Beneficial effect of fenoldopam mesylate in preventing peak blood lactate level during cardiopulmonary bypass for paediatric cardiac surgery.
Ressia Laura, Calevo Maria Grazia, Lerzo Franco et al. · Interact Cardiovasc Thorac Surg · 2014
PMID: 24771205Trial
Fenoldopam mesylate in early acute tubular necrosis: a randomized, double-blind, placebo-controlled clinical trial.
Tumlin James A, Finkel Kevin W, Murray Patrick T et al. · Am J Kidney Dis · 2005
PMID: 15983954Trial
N-Acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity.
Briguori Carlo, Colombo Antonio, Airoldi Flavio et al. · J Am Coll Cardiol · 2004
PMID: 15312855Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Fenoldopam mesilate (substance)
SNOMED CT
108591003
UMLS CUI
C0700481

Clinical Data

This intervention maps to 10 entities in the Healos knowledge graph.

3
Conditions
4
Biomarkers
2
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.